North America Histology and Cytology Market

North America Histology and Cytology Market Size (2024 to 2029)

The North American histology and cytology market is estimated to be worth USD 7.14 billion in 2024 and USD 15.41 billion by 2029, growing at a CAGR of 16.64% from 2024 to 2029.

Cytology is the microscopic examination of cell samples collected from any body area, including the lungs, vagina, kidney, and others, to determine the presence of abnormal growths or lumps on the body's surface. Cytology can also be performed to evaluate abnormal bodily fluid accumulations in the chest and abdomen. The most frequent approach for collecting cytology cell samples is fine needle biopsy, also known as fine-needle aspiration. A sterile needle attached to an empty syringe is introduced into the target region to aspirate either cells or bodily fluid.

The increasing prevalence of chronic diseases such as cancer and other infectious diseases, the growing demand for early detection of viruses and standardization of pathology laboratories, advances in microscopy, and implementation of immunohistochemistry are primarily boosting the histology and cytology market in the North American region. In addition, the technological advancements in the healthcare sector and the growing adoption of innovative products in immunohistochemistry are further boosting the growth of the histology and cytology market in North America. Furthermore, the introduction of digital solutions into cytological diagnosis can allow for the rapid evaluation of primary diagnostic data.

The growing popularity of immunohistochemistry for visualizing cellular components to diagnose a wide range of disorders, such as cancer and other infectious diseases, is expected to favor the North American market during the forecast period. On the other hand, the key market players in the region are focussing on introducing new products, and new product developments are expected to expand the market growth. Furthermore, to gain a competitive advantage over the marketplace, the market players adopt various market strategies such as partnerships, mergers, and acquisitions. 

However, stringent government regulations and the associated complicated procedures with histology and cytology are predicted to hamper the market's growth rate during the forecast period. 

This report has been segmented and sub-segmented into the following categories.

By Examination Type:

• Histology
• Cytology

By Test Type:

• Microscopy tests
  • Cytogenic tests
    • Karyotyping
    • Fluorescent In-situ Hybridization (FISH)
  • Polymerase Chain Reaction
  • Others
• Molecular genetics tests
• Flow cytometry
• Others

By End-use:

• Hospitals
• Diagnostic Laboratories
• Academic & Research Institutes
• Others

By Country:

• The United States
• Canada
• Rest of North America

Geographically, North America played the leading role in the global histology and cytology market in 2021 and accounted for 40%. The regional market growth is attributed to the availability of advanced healthcare infrastructure, high healthcare spending, and favorable reimbursement policies. In addition, the presence of key market players and the global level emerging players such as the United States and Canada are expanding the regional market growth.

The United States accounted for the majority share of the North American histology and cytology market, and it is projected to record a substantial share during the forecast period. Factors such as the high prevalence of infectious diseases and chronic diseases such as cancer propel market growth. In addition, the US is witnessed technological advancements in the healthcare sector, research and development activities, and increasing investments by the government and non-government organizations are uplifting the market growth.

Similarly, the Canadian market is estimated to witness a considerable share due to the rising awareness, advancing healthcare infrastructure, and the growing application of histopathology studies for the diagnosis of different types of cancer. Furthermore, the histology and cytology market has seen significant expansion in the healthcare industry, as these clinical studies can diagnose various severe disorders. In addition, it has been discovered that several infectious diseases, such as cancer, can be identified.

KEY MARKET PLAYERS:

Abbott Laboratories, Thermo Fisher Scientific, Merck and Co., F. Hoffmann-La Roche, Becton Dickinson & Company, Danaher Corporation, Sysmex Corporation are a few of the notable players in the North American histology and cytology market profiled in this report.